DONNELLY B HOWARD

Allopathic & Osteopathic Physicians|Internal Medicine MOBILE, AL NPI 1689613473

General Payments — all program years on this page

$1,570.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $240.56 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $240.5614

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $35.002
2019 $20.771
2021 $164.7910
2022 $642.2741
2023 $467.0532
2024 $240.5614

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086932825 Novartis Pharmaceuticals Corporation $17.56 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097562456 Novo Nordisk Inc $13.11 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097678129 Novo Nordisk Inc $14.19 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103943311 ABBVIE INC. $14.31 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104656811 AstraZeneca Pharmaceuticals LP $15.18 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105513057 AstraZeneca Pharmaceuticals LP $15.16 06/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105629488 AstraZeneca Pharmaceuticals LP $20.79 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105663548 AstraZeneca Pharmaceuticals LP $16.80 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116651653 GlaxoSmithKline, LLC. $15.62 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136160819 Lilly USA, LLC $15.89 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138557353 Exelixis Inc. $23.67 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141613976 Merck Sharp & Dohme LLC $14.40 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144592994 Xeris Pharmaceuticals, Inc. $24.17 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153570008 Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.71 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.